Commentary: The American Red Cross reported that the national blood supply was down 35% — partly the result of extreme winter ...

His neck and underarms were swollen. His skin itched, particularly on his arms. Sleeping at night was impossible.

Beijing-based pharma, BeiGene’s Brukinsa (zanubrutinib) has been approved by the US Food and Drug Administration (FDA) for chronic lymphocytic leukaemia (CLL) and small lymphocytic lymphoma (SLL). CLL ...

FDA fast track designation covers R/R CLL/SLL and R/R MZL, expanding prior fast track status in R/R DLBCL and potentially enabling rolling review and expedited registrational planning. Interim phase ...

His neck and underarms were swollen. His skin itched, particularly on his arms. Sleeping at night was impossible. His symptoms started when he was 50. Though he had been fit and healthy all his life, ...

This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license. This work is licensed under a Creative Commons ...

For (adult) patients with relapsed or refractory chronic lymphocytic leukemia (CLL), a new line of treatment has been ...